H-AAVKNWMTQTL-OH

Ref. 3D-PP44331

Informations sur le produit

• Nom: H-AAVKNWMTQTL-OH
• Synonymes: NH2-Ala-Ala-Val-Lys-Asn-Trp-Met-Thr-Gln-Thr-Leu-OH

Description

Peptide H-AAVKNWMTQTL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AAVKNWMTQTL-OH include the following: Pulmonary delivery of mucosal nanovaccines W Tang , Y Zhang, G Zhu - Nanoscale, 2022 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2007/0o/d1nr06512b Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines SM Sumida, PF McKay , DM Truitt - The Journal of , 2004 - Am Soc Clin Investighttps://www.jci.org/articles/view/22608 Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein SM Sumida, DM Truitt, AAC Lemckert - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/174/11/7179/101610 Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions RR Bradley, LF Maxfield, DM Lynch - Journal of , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.06165-11 Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection RR Bradley, DM Lynch, MJ Iampietro - Journal of , 2012 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.06254-11 Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors P Abbink, LF Maxfield, D Ng'ang'a - Journal of , 2015 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02950-14 Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D P Abbink, AAC Lemckert, BA Ewald, DM Lynch - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02696-06 Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses NM Provine , RA Larocca - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/192/11/5214/92520 Immunogenicity and cross-reactivity of rhesus adenoviral vectors MJ Iampietro , RA Larocca , NM Provine - Journal of , 2018 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00159-18 Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human KM Quinn , A Da Costa, A Yamamoto - The Journal of , 2013 - journals.aai.orghttps://journals.aai.org/jimmunol/article/190/6/2720/87071 Comparative Analysis of the Magnitude, Quality, Phenotype and Protective Capacity of SIV Gag-Specific CD8+ T Cells Following Human-, Simian-and KM Quinn , A Da Costa, A Yamamoto - (Baltimore, Md.: 1950 , 2013 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594325/ Regulatory T Cells Suppress Natural Killer Cells during Plasmid DNA Vaccination in Mice, Blunting the CD8+ T Cell Immune Response by the Cytokine TGFbeta K Frimpong-Boateng, N van Rooijen , R Geiben-Lynn - PloS one, 2010 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012281 Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectors JE Teigler, P Penaloza-MacMaster - Clinical and Vaccine , 2014 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/cvi.00207-14 Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys J Liu, BA Ewald, DM Lynch, M Denholtz - Journal of , 2008 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02616-07 Modulation of DNA Vaccine-Elicited CD8+ T-Lymphocyte Epitope Immunodominance Hierarchies J Liu, BA Ewald, DM Lynch, A Nanda - Journal of , 2006 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01348-06 Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors EG Rhee, JN Blattman , SP Kasturi , RP Kelley - Journal of , 2011 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01597-10 Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination DR Kaufman, J Liu, A Carville - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article/181/6/4188/84671 Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity DM Roberts, A Nanda, MJE Havenga , P Abbink - Nature, 2006 - nature.comhttps://www.nature.com/articles/nature04721 Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity DH Barouch , MG Pau, JHHV Custers - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/10/6290/36288 Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity AR Thorner, AAC Lemckert, J Goudsmit - Journal of , 2006 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01749-06 Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 AAC Lemckert, SM Sumida, L Holterman - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.79.15.9694-9701.2005 Adenoviral vectors: a possible road to an HIV vaccine AAC Lemckert - 2008 - dare.uva.nlhttps://dare.uva.nl/document/2/53333 Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys A Nanda, DM Lynch, J Goudsmit, AAC Lemckert - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.79.22.14161-14168.2005 Combined HDAC and BET inhibition enhances melanoma vaccine immunogenicity and efficacy A Badamchi-Zadeh , KD Moynihan - The Journal of , 2018 - journals.aai.orghttps://journals.aai.org/jimmunol/article/201/9/2744/107111

• Marque: Biosynth